Karen Liu

Karen Liu is a Director at Ansun Biopharma and a Board Member at Oncoimmune Inc. Karen has also served as a Partner at Kaiwu Capital and as COO/ acting CFO /SVP at 3721.com (Inter China Network Software). Prior to their current positions, they were an Associate / Project manager at McKinsey & Company.

Liu has over 20 years of experience in the biotech and pharmaceutical industries. Karen has expertise in strategy, operations, business development, and finance. Karen has a proven track record of success in building and leading high-performing teams.

Liu earned their MBA from Harvard Business School and their BA from Yale University.

Karen Liu has a Ph.D from Harvard University, an MMS from Harvard Medical School, a BS from Cornell University, and an EMBA from the CK Graduate School of Business (CKGSB).